Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Apr;25(4):513–514. doi: 10.1128/aac.25.4.513

Ceftazidime nephrotoxicity in rats.

F C Luft, D W Visscher, D M Nierste, D K Blase, N A Walker, G R Aronoff
PMCID: PMC185567  PMID: 6375559

Abstract

The nephrotoxicity of ceftazidime compared with that of cefazolin or cephaloridine and the capacity of ceftazidime to enhance the nephrotoxicity of tobramycin were evaluated in rats. Only cephaloridine and tobramycin given alone altered creatinine clearance or caused significant histological injury. Our data suggest that ceftazidime is no more nephrotoxic than cefazolin and does not enhance the nephrotoxicity of tobramycin.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronoff G. R., Brier M. E., Nierste D. M., Sloan R. S. Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function. J Infect Dis. 1984 Jan;149(1):9–15. doi: 10.1093/infdis/149.1.9. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Chopra I., Howe T. G., Linton A. H., Linton K. B., Richmond M. H., Speller D. C. The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother. 1981 Jul;8(1):5–21. doi: 10.1093/jac/8.1.5. [DOI] [PubMed] [Google Scholar]
  4. Kim K. E., Onesti G., Ramirez O., Brest A. N., Swartz C. Creatinine clearance in renal disease. A reappraisal. Br Med J. 1969 Oct 4;4(5674):11–14. doi: 10.1136/bmj.4.5674.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Luft F. C., Bloch R., Sloan R. S., Yum M. N., Costello R., Maxwell D. R. Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis. 1978 Oct;138(4):541–545. doi: 10.1093/infdis/138.4.541. [DOI] [PubMed] [Google Scholar]
  6. Norrby S. R., Burman L. A., Linderholm H., Trollfors B. Ceftazidime: pharmacokinetics in patients and effects on the renal function. J Antimicrob Chemother. 1982 Sep;10(3):199–206. doi: 10.1093/jac/10.3.199. [DOI] [PubMed] [Google Scholar]
  7. Wade J. C., Smith C. R., Petty B. G., Lipsky J. J., Conrad G., Ellner J., Lietman P. S. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet. 1978 Sep 16;2(8090):604–606. doi: 10.1016/s0140-6736(78)92825-8. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES